Influence of Cytochrome P450 3A4 (CYP3A4)-Induction by St. John's Wort (SJW) on the Steady State Pharmacokinetics of Bosentan.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2017
At a glance
- Drugs Bosentan (Primary) ; Hypericum
- Indications Depression; Hypertension
- Focus Pharmacokinetics
- 01 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jan 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 20 Dec 2010 New trial record